Revisions for A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer. | Registro Público Cubano de Ensayos Clínicos

Published clinical_trials A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer. has 5 revisions.

Revision		Status
Saved 31/07/2023 - 11:34am by ROCHE		in draft/pending publication
Saved 19/07/2023 - 3:03pm by Gladys		current revision (published)
Saved 18/08/2021 - 11:07am by ROCHE Buen día estimados, A continuación la más reciente actualización del estudio. Saludos,		archived
Saved 17/08/2021 - 12:43pm by ROCHE		archived
Saved 10/07/2018 - 8:48am by Gladys		archived

Registered Trials

Registration process

About the RPCEC

Useful resources